The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.70

Today's change+0.10 +6.25%
Updated December 18 3:58 PM EST. Delayed by at least 15 minutes.
 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.70

Today's change+0.10 +6.25%
Updated December 18 3:58 PM EST. Delayed by at least 15 minutes.

Helix Biopharma Corp crosses above 20-day moving average

Helix Biopharma Corp closed up sharply Thursday, rallying $0.10 or 6.25% to $1.70 and crossing above its 20-day moving average. Over the last five days, shares have gained 3.03% and 18.06% year to date. Shares have outperformed the S&P TSX by 17.41% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated December 18 3:58 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJul 31, 201407/31/2014Apr 30, 201404/30/2014Jan 31, 201401/31/2014Oct 31, 201310/31/2013
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2232
Selling / general / administrative1111
Research & development1121
Depreciation / amortization000--
Interest expense (income), net operating--------
Unusual expense (income)000--
Other operating expenses, total--------
Operating income-2-2-3-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-2-3-2
Income after tax-2-2-3-2
Income tax, total0000
Net income-2-2-3-2
Total adjustments to net income--------
Net income before extra. items-2-2-3-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-3-2
Inc. avail. to common incl. extra. items-2-2-3-2
Diluted net income-2-2-3-2
Dilution adjustment--00--
Diluted weighted average shares73727267
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.03-0.04-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.03-0.04-0.03